申请人:LY Tai Wei
                            
                            
                                公开号:US20120088769A1
                            
                            
                                公开(公告)日:2012-04-12
                            
                            Provided herein are arylsulfonamide salts, e.g., a salt of a compound of Formula I, which are useful for modulating CCR3 activity, and their pharmaceutical compositions. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.